Skip to main content

View full-text article in PMC

. 2020 Apr;12(2):121–126.

Table 8.

Antimicrobial activity of investigated nanoclay based nanocomposites

Microorganisms	Samples of nanoclay based nanocomposites (wt%)

	1N:1C	1N:3C	1N:5C	3N:1C	3N:3C	3N:5C	5N:1C	5N:3C	5N:5C

	Inhibition zone diameter (mm)
E. coli	28 ± 0.67^f	32 ± 0.67^e	25 ± 0.67^l	29 ± 0.67^h	27 ± 0.67^j	24 ± 0.67^m	24 ± 0.67^m	22 ± 0.67ⁿ	20 ± 0.67^p
S. enterica	38 ± 0.67^a	38 ± 0.67^a	32 ± 0.67^e	36 ± 0.67^c	37 ± 0.67^b	29 ± 0.67^h	28 ± 0.67ⁱ	24 ± 0.67^m	21 ± 0.67^o
S. aureus	30 ± 0.67^g	35 ± 0.67^d	24 ± 0.6^m	28 ± 0.67ⁱ	31 ± 0.67^f	25 ± 0.67^l	26 ± 0.67^k	21 ± 0.67^o	19 ± 0.67^q
A. brasiliensis	14 ± 0.67^t	16 ± 0.67^r	13 ± 0.67^u	11 ± 0.6^w	13 ± 0.67^u	12 ± 0.67^v	12 ± 0.67^v	11 ± 0.67^w	0 ± 0.67^z
S. cerevisiae	14 ± 0.67^t	15 ± 0.67^s	12 ± 0.67^v	12 ± 0.67^v	12 ± 0.67^v	11 ± 0.6^w	11 ± 0.67^w	11 ± 0.67^w	11 ± 0.6^w

The results were reported as mean ± SD. The different letters in each column indicate significant differences.

C: Chitosan

N: Nanoclay